Predose

Precision Dosing at Scale

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2024 by Gary Schonberg, Predose operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its automated platform for precision drug-dosing regimens. In January 2025, Predose was selected as one of nine Israeli startups to assist the UK in improving its healthcare system.

Business overview

Predose is developing an automated platform that leverages patient-specific data and cloud-based technology to customize individual drug-dosing regimens directly at the clinic and optimize clinical workflows. The software integrates drug-specific clinical knowledge into mechanistic models, utilizes patient-specific covariates to create personalized "virtual twins," and automates the end-to-end precision dosing workflow. The company operates in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Medical Decision Support, serving healthcare providers with its B2B business model.

Strategic signal

In January 2025, Predose was recognized as one of nine Israeli startups selected to contribute to improving the UK's healthcare system. This selection highlights the potential impact of Predose's precision dosing technology on a national scale, signaling strong external validation and potential for international market expansion for its automated platform.

Company Intelligence Q&A

When was Predose founded?
Predose was founded in January 2024.
Who is the founder of Predose?
Gary Schonberg is the founder of Predose.
What is Predose's primary focus?
Predose focuses on developing an automated platform for precision drug-dosing regimens, utilizing patient-specific data and cloud-based technology to optimize clinical workflows.
In which sector does Predose primarily operate?
Predose operates primarily in the Health Tech & Life Sciences sector, specifically within Digital Healthcare and Medical Decision Support.
What significant recognition did Predose receive in early 2025?
In January 2025, Predose was selected as one of nine Israeli startups to help the UK improve its healthcare system, highlighting the potential of its technology on an international level.